Literature DB >> 18395684

Differential effects of sex steroids in young and aged female mRen2.Lewis rats: a model of estrogen and salt-sensitive hypertension.

Mark C Chappell1, Brian M Westwood, Liliya M Yamaleyeva.   

Abstract

BACKGROUND: Male-female differences in the expression of hypertension and in end-organ damage are evident in both experimental models and human subjects, with males exhibiting a more rapid onset of cardiovascular disease and mortality than do females. The basis for these male-female differences is probably the balance of the complex effects of sex steroids (androgens, estrogen, progesterone) and their metabolites on the multiple regulatory systems that influence blood pressure (BP). A key target of estrogen and other steroids is likely to be the different components of the renin-angiotensin-aldosterone system (RAAS).
OBJECTIVE: The aim of this study was to review the current experimental evidence on the protective effects of estrogen in hypertensive models.
METHODS: The search terms estrogen , renin-aangiotensin-aldosterone system, renin receptor, salt-sensitivity, endorgan damage, hypertension, kidney, mRen2. Lewis, and injury markers were used to identify relevant publications in the PubMed database (restricted to the English language) from January 1990 to October 2007.
RESULTS: In a new congenic model that expresses the mouse renin 2 gene (mRen2. Lewis), estrogen depletion (via ovariectomy [OVX ]) in young rats was found to have a marked stimulatory effect on the progression of increased BP and cardiac dysfunction. Moreover, estrogen depletion exacerbated salt-sensitive hypertension and the extent of salt-induced cardiac and renal injury in young mRen2. Lewis rats, which probably reflected the inability to appropriately regulate various components of the RAAS. However, OVX in aged mRen2. Lewis rats conveyed renal protective effects from a high-salt diet compared with intact hypertensive littermates (64 weeks), and these effects were independent of changes in BP.
CONCLUSION: These studies in hypertensive mRen2. Lewis rats underscored the influence of ovarian hormones on BP and tissue injury, as well as the plasticity of this response, apparently due to age and salt status.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395684      PMCID: PMC2536743          DOI: 10.1016/j.genm.2008.03.007

Source DB:  PubMed          Journal:  Gend Med        ISSN: 1550-8579


  52 in total

1.  Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5' leader sequence of the receptor mRNA.

Authors:  K Krishnamurthi; J G Verbalis; W Zheng; Z Wu; L B Clerch; K Sandberg
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

Review 2.  Hypertension in women.

Authors:  T Rosenthal; S Oparil
Journal:  J Hum Hypertens       Date:  2000 Oct-Nov       Impact factor: 3.012

3.  Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2. Lewis rat.

Authors:  Mark C Chappell; Patricia E Gallagher; David B Averill; Carlos M Ferrario; K Bridget Brosnihan
Journal:  Hypertension       Date:  2003-07-21       Impact factor: 10.190

4.  Characterization of an animal model of postmenopausal hypertension in spontaneously hypertensive rats.

Authors:  Lourdes A Fortepiani; Huimin Zhang; Lorraine Racusen; L Jackson Roberts; Jane F Reckelhoff
Journal:  Hypertension       Date:  2002-12-09       Impact factor: 10.190

5.  Estrogen depletion induces NaCl-sensitive hypertension in female spontaneously hypertensive rats.

Authors:  Z Fang; S H Carlson; Y F Chen; S Oparil; J M Wyss
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-12       Impact factor: 3.619

6.  Permissive role of nitric oxide in macula densa control of renin secretion.

Authors:  Hayo Castrop; Frank Schweda; Diane Mizel; Yuning Huang; Josie Briggs; Armin Kurtz; Jurgen Schnermann
Journal:  Am J Physiol Renal Physiol       Date:  2004-01-13

7.  Renal hemodynamic and tubular responses to salt in women using oral contraceptives.

Authors:  Antoinette Pechère-Bertschi; Marc Maillard; Hans Stalder; Paul Bischof; Marc Fathi; Hans R Brunner; Michel Burnier
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

8.  Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Authors:  Deborah Grady; David Herrington; Vera Bittner; Roger Blumenthal; Michael Davidson; Mark Hlatky; Judith Hsia; Stephen Hulley; Alan Herd; Steven Khan; L Kristin Newby; David Waters; Eric Vittinghoff; Nanette Wenger
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

9.  Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene.

Authors:  Ovidiu Baltatu; Cécile Cayla; Radu Iliescu; Dmitrii Andreev; Cynthia Jordan; Michael Bader
Journal:  J Am Soc Nephrol       Date:  2002-11       Impact factor: 10.121

10.  Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity.

Authors:  Lisa M Harrison-Bernard; Ivonne Hernandez Schulman; Leopoldo Raij
Journal:  Hypertension       Date:  2003-11-10       Impact factor: 10.190

View more
  28 in total

1.  Prenatal testosterone exposure leads to hypertension that is gonadal hormone-dependent in adult rat male and female offspring.

Authors:  Vijayakumar Chinnathambi; Meena Balakrishnan; Chandrasekhar Yallampalli; Kunju Sathishkumar
Journal:  Biol Reprod       Date:  2012-05-03       Impact factor: 4.285

2.  Rosiglitazone reduces blood pressure in female Dahl salt-sensitive rats.

Authors:  Julio C Sartori-Valinotti; Marcia R Venegas-Pont; Babbette B Lamarca; Damian G Romero; Licy L Yanes; Lorraine C Racusen; Allison V Jones; Michael J Ryan; Jane F Reckelhoff
Journal:  Steroids       Date:  2009-10-31       Impact factor: 2.668

3.  Chronic Estrogen Supplementation Prevents the Increase in Blood Pressure in Female Intrauterine Growth-Restricted Offspring at 12 Months of Age.

Authors:  Gwendolyn K Davis; Ashley D Newsome; Alyssa B Cole; Norma B Ojeda; Barbara T Alexander
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

Review 4.  Role of estrogen in diastolic dysfunction.

Authors:  Zhuo Zhao; Hao Wang; Jewell A Jessup; Sarah H Lindsey; Mark C Chappell; Leanne Groban
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

Review 5.  STIM and Orai proteins: players in sexual differences in hypertension-associated vascular dysfunction?

Authors:  Fernanda R C Giachini; R Clinton Webb; Rita C Tostes
Journal:  Clin Sci (Lond)       Date:  2009-12-15       Impact factor: 6.124

6.  Refractory blood pressure in female SHR to increased oxidative stress is not mediated by NO or by upregulation of renal antioxidant enzymes.

Authors:  Arnaldo F Lopez-Ruiz; Radu Iliescu; Jane F Reckelhoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-16       Impact factor: 3.619

Review 7.  Sex differences in control of blood pressure: role of oxidative stress in hypertension in females.

Authors:  Arnaldo Lopez-Ruiz; Julio Sartori-Valinotti; Licy L Yanes; Radu Iliescu; Jane F Reckelhoff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

8.  Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis rats.

Authors:  Jewell A Jessup; Sarah H Lindsey; Hao Wang; Mark C Chappell; Leanne Groban
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

9.  Estrogen therapy, independent of timing, improves cardiac structure and function in oophorectomized mRen2.Lewis rats.

Authors:  Jewell A Jessup; Hao Wang; Lindsay M MacNamara; Tennille D Presley; Daniel B Kim-Shapiro; Lili Zhang; Alex F Chen; Leanne Groban
Journal:  Menopause       Date:  2013-08       Impact factor: 2.953

10.  Breaking the Cycle: Estrous Variation Does Not Require Increased Sample Size in the Study of Female Rats.

Authors:  Alex Dayton; Eric C Exner; John D Bukowy; Timothy J Stodola; Theresa Kurth; Meredith Skelton; Andrew S Greene; Allen W Cowley
Journal:  Hypertension       Date:  2016-09-26       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.